参考文献/References:
[1]Molodecky NA,Soon IS,Rabi DM,et al. Increasing inci?dence and prevalence of the inflammatory bowel diseases
with time,based on systematic review[J]. Gastroenterolo?gy,2012,142( 1) : 46 - 54.
[2]Ooi CJ,Fock KM,Makharia GK,et al. The Asia - Pacific
consensus on ulcerative colitis[J]. J Gastroenterol Hepa?tol. 2010,25( 3) : 453 - 468.
[3]于兰,杨云生. MicroRNAs 在消化道疾病中的作用研
究进展[J]. 解放军医学杂志,2013,38( 12) : 1026 -
1031.
[4]Mehta A,Baltimore D. MicroRNAs as regulatory elements
in immune system logic[J]. Nature Reviews Immunology,
2016,16( 5) : 279 - 294.
[5]Baek D,Villen J,Shin C,et al. The impact of microR-
NAs on protein output[J]. Nature,2008,455( 7209) :
64 - 71.
[6]Wang F,Xia J,Wang N,et al. miR - 145 Inhibits Prolif?eration and Invasion of Esophageal Squamous Cell Carcino?ma in Part by Targeting c - Myc[J]. Onkologie,2013,36
( 12) : 754 - 758.
[7]Chen YJ,Thang MW,Chan YT,et al. Global assessment of
Antrodia cinnamomea - Induced microRNA alternations in
hepatocarcinoma Cells[J]. PLoS One,2013,8 ( 12 ) :
e82751.
[8]Josse C,Bouznad N,Geurts P,et al. Identification of a
microRNA landscape targeting the PI3K/Akt signaling
pathway in inflammation - induced colorectal carcinogene?sis[J]. Am J Physiol Gastrointest Liver Physiol,2014,306
( 3) : G229 - 243.
[9]McGovern D P B,Gardet A,Trkvist L,et al. Genome -
wide association identifies multiple ulcerative colitis sus?ceptibility loci[J]. Nature genetics,2010,42 ( 4) : 332
- 337.
[10]Barrett J C,Lee J C,Lees C W,et al. Genome - wide as?sociation study of ulcerative colitis identifies three new
susceptibility loci,including the HNF4A region[J]. Na?ture genetics,2009,41( 12) : 1330 - 1334.
[11]Asano K,Matsushita T,Umeno J,et al. A genome -
wide association study identifies three new susceptibility
loci for ulcerative colitis in the Japanese population[J].
Nature genetics,2009,41( 12) : 1325 - 1329.
[12]Okubo M,Tahara T,Shibata T,et al. Association study
of common genetic variants in pre - microRNAs in pa?tients with ulcerative colitis[J]. Journal of clinical im?munology,2011,31( 1) : 69 - 73.
[13]Brase J C,Wuttig D,Kuner R,et al. Serum microRNAs
Jan. 2017 Vol. 37 No. 1
2017 年 1 月第 37 卷第 1 期 现 代 中 医 药
Modern Traditional Chinese Medicine ·85·
as non - invasive biomarkers for cancer[J]. Molecular
cancer,2010,9( 1) : 1.
[14]Gilad S,Meiri E,Yogev Y,et al. Serum microRNAs are
promising novel biomarkers[J]. PloS one,2008,3( 9) :
e3148.
[15]Zhang Y,Liu D,Chen X,et al. Secreted monocytic miR
- 150 enhances targeted endothelial cell migration[J].
Molecular cell,2010,39( 1) : 133 - 144.
[16]Arroyo J D,Chevillet J R,Kroh E M,et al. Argonaute2
complexes carry a population of circulating microRNAs
independent of vesicles in human plasma[J]. Proceedings of the National Academy of Sciences,2011,108
( 12) : 5003 - 5008.
[17]铁轶,付汉江,郑晓飞. 循环 microRNA 与肿瘤诊断
[J]. 中国科学: C 辑,2009,39( 1) : 64 - 68.
[18]Mitchell P S,Parkin R K,Kroh E M,et al. Circulating
microRNAs as stable blood - based markers for cancer
detection[J]. Proceedings of the National Academy of
Sciences,2008,105( 30) : 10513 - 10518.
[19]Valadi H,Ekstrm K,Bossios A,et al. Exosome - mediated transfer of mRNAs and microRNAs is a novel
mechanism of genetic exchange between cells[J]. Nature
cell biology,2007,9( 6) : 654 - 659.
[20]Chen X,Ba Y,Ma L,et al. Characterization of microR-
NAs in serum: a novel class of biomarkers for diagnosis
of cancer and other diseases[J]. Cell research,2008,
18( 10) : 997 - 1006.
[21]Wu F,Zi ku soka M,TrindadeA ,et al. MicroRNAs are
differentially expressed in ulcerative colitis and alter expression macrophage inflammatory peptide - 2 alpha[J].
Gastroenterology,2008,135( 5) : 1624 - 1635.
[22]Wu F,Guo NJ,Tian H,et al. Peripheral blood microR-
NAs distinguish active ulcerative colitis and Crohn’s disease[J]. Inflamm Bowel Dis,2011,17( 1) : 241 - 250.
[23]Yang Y,Ma Y,Shi C. Overexpression of miR - 21 in patients with ulcerative colitis impairs intestinal epithelial
barrier function through targeting the Rho GTPase RhoB.
Biochem Biophys Res Commun 434: 746 - 752.
[24]Paraskevi A,Theodoropoulos G,Papaconstantinou I et
al. Circulating MicroRNA in inflammatory bowel disease. J Crohns Colitis 6: 900 - 904.
[25]Fisher K,Lin J. MicroRNA in inflammatory bowel disease: Translational research and clinical implication[J].
World journal of gastroenterology, 2015, 21 ( 43 ) :
12274.
[26]Zahm A M,Hand N J,Tsoucas D M,et al. Rectal microRNAs are perturbed in pediatric inflammatory bowel
disease of the colon[J]. Journal of Crohn’s and Colitis,
2014,8( 9) : 1108 - 1117.
[27]Iborra M,Bernuzzi F,Correale C,et al. Identification of
serum and tissue micro ‐ RNA expression profiles in different stages of inflammatory bowel disease[J]. Clinical
& Experimental Immunology,2013,173 ( 2 ) : 250 -
258.
[28]Duttagupta R,DiRienzo S,Jiang R,et al. Genome -
wide maps of circulating miRNA biomarkers for ulcerative
colitis[J]. PloS one,2012,7( 2) : e31241.
[29]Wang K,Yuan Y,Cho J H,et al. Comparing the MicroRNA spectrum between serum and plasma[J]. PloS
one,2012,7( 7) : e41561.
[30]张声生,李乾构. 溃疡性结肠炎中医诊疗共识意见
[J]. 中华中医药杂志,2010,25( 6) : 891 - 895.
[31]李建华. 论痈与溃疡性结肠炎[J]. 辽宁中医药大学学
报,2010,12( 5) : 123 - 124.
[32]黄海龙,陈刚. 中西医结合对溃疡性结肠炎血瘀证的
研究现状[J]. 中国中西医结合消化杂志,2011,19( 5) : 342 - 344.
[33]徐阳. 初探溃疡性结肠炎发病因素与痰瘀相关的回顾
性研究[D]. 沈阳: 辽宁中医药大学,2013.
[34]许清华,郝会莲,毛艳,等. 从虚论治慢性溃疡性结肠
炎[J]. 西部中医药,2011,24( 12) : 100 - 102.
[35]李军. 基于“脏腑风湿”理论的溃疡性结肠炎从痹辨治
思路[J]. 江苏中医药,2014,46( 3) : 8 - 10.
[36]李倩,周铭心. 基于二次文献的溃疡性结肠炎证候分
析[J]. 中华中医药杂志,2014,29( 4) : 1236 - 1239.
[37]张家仕. miRNA - 499 与冠心病中医证型的相关性研
究[D]. 广州: 广州中医药大学,2014.
[38]冯知涛. RA 患者外周血 miR - 146a、miR - 16 表达与
疾病活动、中医证型相关性及青藤碱制剂对其干预的
研究[D]. 深圳: 南方医科大学,2011.
[39]袁雅琪. 干燥综合征阴虚证患者中 miR - 17 - 92 的
表达与临床谱及中医证型的相关性研究[D]. 南京:
南京中医药大学,2014.
[40]原宁. 结直肠腺瘤中医虚实证候 miRNA 表达谱的研
究[D]. 广州: 广州中医药大学,2012.
相似文献/References:
[1]李盼盼,李东阳,李 毅.白头翁汤治疗溃疡性结肠炎作用机制研究进展[J].现代中医药,2019,(06):130.[doi:10.13424/j.cnki.mtcm.2019.06.039]
[2]惠建萍1,杜晓泉2,张耀之1,等.通因通用法辨治溃疡性结肠炎的思路与方法[J].现代中医药,2019,(05):033.[doi:10.13424/j.cnki.mtcm.2019.05.011]
[3]史 英1 张 铁2 张 鹏1 吴洁琼1 孙 杰1 相祎1 张 伟1 吴 婷1 杨银利1 郑荣心1 张 莹1.结肠止泻汤治疗溃疡性结肠炎脾虚湿阻证的临床研究[J].现代中医药,2019,(04):076.[doi:10.13424/j.cnki.mtcm.2019.04.023]
[4]陈佳 姜小帆 马寅伍.小柴胡汤合桃花汤治疗溃疡性结肠炎疗效观察及对炎症因子的影响研究[J].现代中医药,2018,(06):061.[doi:10.13424/j.cnki.mtcm.2018.06.021]
[5]李 毅** 刘 艳*** 王小平 蔺焕萍 唐梦凡 孙 婳.溃疡性结肠炎不同证候结肠黏膜microRNA差异表达的初步研究[J].现代中医药,2017,(01):023.[doi:10.13424/j.cnki.mtcm.2017.01.010]
[6]王会录,王孝郎.黄芩汤加味辅助美沙拉嗪治疗溃疡性结肠炎39例[J].现代中医药,2019,(03):056.[doi:10.13424/j.cnki.mtcm.2019.03.018]
[7]李东阳,李盼盼.参苓白术散治疗溃疡性结肠炎作用机制研究进展[J].现代中医药,2019,(03):114.[doi:10.13424/j.cnki.mtcm.2019.03.035]
[8]屈 杰,李小会,谭颖颖,等.解毒化瘀方对溃疡性结肠炎大鼠 TLR4、NF-κB的影响[J].现代中医药,2020,(01):024.[doi:10.13424/j.cnki.mtcm.2020.01.006]
Qu Jie,Li Xiaohui,Tan Yingying,et al.Effect of Toxicity and Blood Stasis Removing Recipe on TLR4 and NF - κ B in Rats with Ulcerative Colitis[J].Modern Traditional Chinese Medicine,2020,(01):024.[doi:10.13424/j.cnki.mtcm.2020.01.006]
[9]杨银利 吴婷 鱼富丽 马小兵 张伟 吴洁琼 相祎.中医综合治疗溃疡性结肠炎老年患者的临床疗效分析[J].现代中医药,2020,(03):073.[doi:10.13424/j.cnki.mtcm.2020.03.020]
Yang Yinli,Wu Ting,Yu Fuli,et al.An Analysis of the Clinical Effect of Treating the UC Inflicted on the Older Patients by Comprehensive Therapy of TCM[J].Modern Traditional Chinese Medicine,2020,(01):073.[doi:10.13424/j.cnki.mtcm.2020.03.020]
[10]陈立平 王国海 周志红 谭仁琼.大柴胡汤治疗溃疡性结肠炎的临床研究[J].现代中医药,2020,(03):088.[doi:10.13424/j.cnki.mtcm.2020.03.024]